Affordable Access

Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma.

Authors
Type
Published Article
Journal
AIDS
0269-9370
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
17
Issue
12
Pages
1787–1793
Identifiers
PMID: 12891064
Source
Medline

Abstract

Receipt of HAART after diagnosis is associated with a significantly longer survival in patients with AIDS-related CNS lymphoma.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F